Regeneron Pharmaceuticals is a biotechnology company that discovers, develops and makes prescription medicines. Its products treat conditions including serious eye diseases, allergic and inflammatory disorders, and certain cancers and rare diseases. The company serves patients and healthcare providers through partnerships with larger drugmakers that help bring its medicines to markets around the world. Regeneron is based in Tarrytown, New York, in the United States, where it carries out much of its research and development work.
Regeneron Pharmaceuticals, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code REGN34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #566 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendFair
69/100
Mixed trend against its averages.
See the numbers →
Above 200-day average4.5%
From 52-week high-9.9%
MomentumStrong
72/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return13.6%
6-month return5.9%
12-month, skipping last month34.8%
Stability (higher is calmer)Weak
50/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)40.8%
Worst drawdown, 1 year (smaller is calmer)-31.0%
LiquidityFair
54/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.05M BRL
Zero-volume days1.7%
IncomeWeak
4/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.3%
Years with dividends2
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 49.91 – 73.12Daily closes, split-adjusted
Signals
50-day average67.66
200-day average62.87
Golden/death cross (60d)Golden, 29 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.43
Technical summary
Daily
Bullish
10 bullish · 4 neutral · 2 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
63.77
Bullish
EMA 10
65.12
Bullish
SMA 20
65.27
Bullish
EMA 20
65.34
Bullish
SMA 50
67.66
Bearish
EMA 50
65.35
Bullish
SMA 100
61.72
Bullish
EMA 100
63.91
Bullish
SMA 200
62.87
Bullish
EMA 200
62.67
Bullish
Oscillators (daily)
RSI (14)
50.55
Neutral
MACD (12, 26)
-0.46
Bearish
Momentum (12)
0.43
Bullish
Stochastic %K (14)
71.63
Neutral
Williams %R (14)
-28.37
Neutral
CCI (20)
22.72
Neutral
Pivot points (classic, last session)
S3
64.93
S2
65.32
S1
65.52
Pivot
65.91
R1
66.11
R2
66.50
R3
66.70
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.23 USD
Yield on today's price
0.34%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
17 Aug 2026
0.0566
19 May 2026
0.0562
19 Feb 2026
0.0580
18 Nov 2025
0.0557
15 Aug 2025
0.0560
19 May 2025
0.0572
19 Feb 2025
0.0588
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
